3.66
price down icon4.40%   -0.20
 
loading
Precedente Chiudi:
$3.86
Aprire:
$3.75
Volume 24 ore:
476.65K
Relative Volume:
0.06
Capitalizzazione di mercato:
$1.09B
Reddito:
$6.23M
Utile/perdita netta:
$-95.90M
Rapporto P/E:
-9.3846
EPS:
-0.39
Flusso di cassa netto:
$-68.47M
1 W Prestazione:
-2.89%
1M Prestazione:
-7.29%
6M Prestazione:
+115.79%
1 anno Prestazione:
+299.52%
Intervallo 1D:
Value
$3.65
$3.76
Intervallo di 1 settimana:
Value
$3.615
$4.00
Portata 52W:
Value
$0.6513
$5.225

Precigen Inc Stock (PGEN) Company Profile

Name
Nome
Precigen Inc
Name
Telefono
301-556-9900
Name
Indirizzo
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Dipendente
25
Name
Cinguettio
@precigen
Name
Prossima data di guadagno
2025-03-19
Name
Ultimi documenti SEC
Name
PGEN's Discussions on Twitter

Confronta PGEN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PGEN
Precigen Inc
3.665 1.31B 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.90 97.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.00 60.19B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
455.22 59.56B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
717.64 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.36 36.14B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-15 Aggiornamento JP Morgan Underweight → Neutral
2024-03-22 Downgrade JP Morgan Neutral → Underweight
2023-05-23 Iniziato JP Morgan Neutral
2022-11-18 Iniziato Cantor Fitzgerald Overweight
2021-02-25 Iniziato Stifel Buy
2021-02-22 Iniziato Wells Fargo Overweight
2021-02-18 Iniziato B. Riley Securities Buy
2020-05-08 Iniziato H.C. Wainwright Buy
Mostra tutto

Precigen Inc Borsa (PGEN) Ultime notizie

pulisher
Sep 23, 2025

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization - Yahoo Finance

Sep 23, 2025
pulisher
Sep 23, 2025

The Outlook For Precigen (NASDAQ:PGEN) - Seeking Alpha

Sep 23, 2025
pulisher
Sep 23, 2025

Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 3,596,892 Shares of Stock - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen (PGEN) Is Up 7.2% After Securing $125M Credit For PAPZIMEOS Commercialization Plans Has The Bull Case Changed? - simplywall.st

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen (NASDAQ:PGEN) Director Randal J. Kirk Sells 1,403,360 Shares - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near? - Yahoo Finance

Sep 23, 2025
pulisher
Sep 22, 2025

Precigen Bets On Gene Therapies After First FDA Approval - Finimize

Sep 22, 2025
pulisher
Sep 21, 2025

Precigen (NASDAQ:PGEN) Stock Price Up 5.2%Time to Buy? - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Death Cross: How does Coherent Corp correlate with NasdaqJuly 2025 Breakouts & Real-Time Volume Spike Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Inspire Investing LLC Makes New Investment in Precigen, Inc. $PGEN - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Growth Review: What are Precigen Incs growth levers2025 EndofYear Setup & Growth Focused Investment Plans - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization - Yahoo Finance

Sep 20, 2025
pulisher
Sep 18, 2025

Investment Review: Can Precigen Inc beat the S P 5002025 EndofYear Setup & Free Community Consensus Stock Picks - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen (NASDAQ:PGEN) Stock Price Down 3.7%What's Next? - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen converts preferred stock into 54.9 million common shares By Investing.com - Investing.com Nigeria

Sep 18, 2025
pulisher
Sep 17, 2025

Precigen Converts Preferred Stock to Common Shares - TipRanks

Sep 17, 2025
pulisher
Sep 17, 2025

Precigen converts preferred stock into 54.9 million common shares - Investing.com India

Sep 17, 2025
pulisher
Sep 17, 2025

Pullback Watch: Can Precigen Inc scale operations efficiently2025 Winners & Losers & Community Verified Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Movement Recap: Is Precigen Inc a play on infrastructure spendingRate Hike & Risk Managed Investment Signals - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Analyst Downgrade: Is Precigen Inc stock a top performer YTDTrade Ideas & Expert Approved Momentum Ideas - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Growth Value: Is Precigen Inc. exposed to political riskJuly 2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Is Precigen Stock Ready For Takeoff? - StocksToTrade

Sep 16, 2025
pulisher
Sep 16, 2025

Resistance Check: Will Precigen Inc stock go up in YEARWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Ideas Watch: Will Precigen Inc stock go up in YEAREarnings Summary Report & Daily Market Momentum Tracking - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Precigen announces up to $125M non-dilutive financing - MSN

Sep 15, 2025
pulisher
Sep 15, 2025

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - Yahoo Finance

Sep 15, 2025
pulisher
Sep 14, 2025

MetLife Investment Management LLC Purchases New Position in Precigen, Inc. $PGEN - MarketBeat

Sep 14, 2025
pulisher
Sep 14, 2025

Precigen Stock Tumbles as Company Undertakes Massive Shares Sale - StocksToTrade

Sep 14, 2025
pulisher
Sep 13, 2025

Could Precigen's (PGEN) New Credit Facility Reshape Its Approach to Shareholder Dilution? - simplywall.st

Sep 13, 2025
pulisher
Sep 12, 2025

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN

Sep 12, 2025
pulisher
Sep 12, 2025

4 years from clinic to approval — Precigen’s ‘unprecedented’ FDA nod and what comes next - PharmaVoice

Sep 12, 2025
pulisher
Sep 12, 2025

EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS - Eastern Progress

Sep 12, 2025

Precigen Inc Azioni (PGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Precigen Inc Azioni (PGEN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
KIRK RANDAL J
Director
Sep 18 '25
Sale
3.86
1,403,360
5,416,970
12,117,429
$35.72
price down icon 0.23%
$83.24
price down icon 1.06%
$29.29
price down icon 0.78%
$98.88
price down icon 0.70%
$139.51
price down icon 0.64%
biotechnology ONC
$330.97
price up icon 0.33%
Capitalizzazione:     |  Volume (24 ore):